Stay updated with breaking news from Active Controlled Crossover Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Completion of Clinical Portion Represents Critical Milestone Towards CommercializationNasal Opioid Abuse Being Explored for PF614Data From Trial Expected in September 2022SAN DIEGO, CA / ACCESSWIRE / August
Press release content from Accesswire. The AP news staff was not involved in its creation.
~ Trial Designed to Test and Confirm Nasal Opioid Manipulation ~SAN DIEGO, CA / ACCESSWIRE / July 13, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC:ENSCW), a clinical-stage
Press release content from Accesswire. The AP news staff was not involved in its creation.